Epilepsy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been found to have at least one harmful or likely harmful change (variant) in one of the specific genes linked to epilepsy and movement disorder conditions. The genes of interest include a long list such as CDKL5, SCN1A, STXBP1, KCNQ2, MECP2, GRIN2B, and many others — a full list can be confirmed with the trial site.
Who may not be able to join:
- People who do not have a harmful or likely harmful genetic variant in any of the genes on the trial's list of genes of interest.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 617-355-0097
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Creation of Biorepository; Assess Health-Related Quality of Life; Understanding of Disease Spectrum; Investigate the Efficacy of Symptomatic Treatments
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.